Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia.

Jean-Louis GeorgesFloriane GillesHélène CochetAlisson BertrandMarie De TournemireVictorien MonguillonMaeva PasqualiniAlix PrevotGuillaume RogerJoseph SabaJoséphine SoltaniMehrsa Koukabi-FradeliziJean-Paul BeressiCécile LaureanaJean-François ProstBernard Livarek

Published in: PloS one (2020)

This study suggests that ACEIs and ARBs are not similarly associated with COVID-19. In this retrospective series, patients with COVID-19 pneumonia more frequently had previous treatment with ARBs compared with patients without COVID-19.

Keyphrases

angiotensin ii
angiotensin converting enzyme
coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
vascular smooth muscle cells
climate change
patient reported outcomes
intensive care unit
binding protein